by The Schmallenberg virus (SBV) is an emergent orthobunyavirus that primarily affects cattle, sheep, and goats. It causes abortions, stillbirths, and congenital malformations in newborn animals. As SBV infections can lead to severe economic losses for farmers due to loss of livestock, different treatment approaches have been developed. Vaccines have been introduced that protect against clinical disease and vertical transmission to the fetus. They provide immunity through neutralizing antibodies that block virus replication. Therapeutics such as antivirals are also being researched, which could inhibit viral entry and RNA synthesis. However, no vaccination or medication has yet been approved for use in the United States.
The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the Global Schmallenberg virus treatment market size is the development of novel vaccines. Researchers are developing DNA vaccines that trigger both humoral and cellular immune responses against the virus. DNA vaccines stimulate long-lasting immunological memory and offer advantages over conventional vaccines like thermal stability and ease of large-scale production. Some vaccines in development utilize recombinant viral proteins to induce neutralizing antibodies. Advancements are also being made in antiviral drug research. Studies show that certain protease and polymerase inhibitors could inhibit viral replication through mechanisms like disrupting polyprotein processing or genomic RNA synthesis. If proven safe and effective for livestock, these new treatment options would provide alternatives to help control SBVD outbreaks and save farms from significant financial losses.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the Schmallenberg Virus Treatment market is moderate. Although new treatment alternatives can bring innovation, established market leaders have significant brand recognition and resource advantages that make it difficult for new entrants.
Bargaining power of buyers: The bargaining power of buyers in the Schmallenberg Virus Treatment market is high. Buyers have a variety of treatment options from different manufacturers to choose from. This gives them leverage to demand lower prices and better services.
Bargaining power of suppliers: The bargaining power of suppliers in the Schmallenberg Virus Treatment market is moderate. While suppliers of raw materials and components have some pricing power, established manufacturers can relatively easily switch to alternative suppliers if needed.
Threat of new substitutes: The threat of new substitutes in the Schmallenberg Virus Treatment market is low. While alternative treatment approaches may emerge, there are currently no close substitutes for existing medical treatment options for the Schmallenberg Virus.
Competitive rivalry: Competition in the Schmallenberg Virus Treatment market is high among leading manufacturers. Players compete based on treatment efficacy, pricing, research & development, and brand reputation.
Key Takeaways
The global Schmallenberg Virus Treatment market is expected to witness high growth. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030.
North America currently dominates the market owing to rising cases in the region and increasing adoption of advanced treatment options. Europe follows North America and accounts for a significant share due to growing awareness regarding the virus. Western Europe is the fastest growing region in the Schmallenberg Virus Treatment market. Countries like Germany, France, and Italy are witnessing increasing demand. Meanwhile, the Asia Pacific region is also emerging as a major market, driven by growing livestock industry and rising healthcare expenditure.
Key players: Key players operating in the Schmallenberg Virus Treatment market are ABB Ltd, Toshiba International Corporation, Hitachi Ltd, Emerson Electric Company, Robert Bosch GmbH, Panasonic Corporation, Omron Corporation, Honeywell International Inc., Siemens AG, Rockwell Automation, Schneider Electric SE, and Mitsubishi Electric Corporation. Players are focusing on new product launches and partnerships to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
